why choose us

First received: January 10, 2023

Clinical Trial: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hematologic Malignancy

Study Type: INTERVENTIONAL


Official Title: Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Maligna

Brief Summary: This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (?/? TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies

Read more